This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors), and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07282158.
Locations matching your search criteria
United States
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer ConsortiumStatus: Active
Contact: Megan J Shen
Phone: 206-667-4172
PRIMARY OBJECTIVES:
I. To adapt the Helping Ovarian Cancer Patients Cope (HOPE) intervention for use with gynecologic oncology clinicians (HOPE-C) based on clinician feedback.
II. To evaluate the levels of feasibility of the adapted version of the HOPE intervention.
III. To evaluate the levels of acceptability of the adapted version of the HOPE intervention.
IV. To evaluate the levels of satisfaction of the adapted version of the HOPE intervention.
V. To evaluate HOPE-C intervention materials and delivery post-intervention among a subset of clinicians who participated in the workshop to inform optimization and delivery of the intervention.
OUTLINE: Clinicians are assigned to 1 of 3 objectives.
OBJECTIVE 1 (DEVELOPMENT OF INTERVENTION): Clinicians review HOPE-C intervention materials and complete an interview on study.
OBJECTIVE 2 (PILOT TRIAL): Clinicians attend HOPE-C sessions (changing their narrative, managing life's uncertainty and finding meaning) over 30-45 minutes, once weekly for 4 weeks. Clinicians complete a questionnaire before and after completing all HOPE-C sessions.
OBJECTIVE 3: Clinicians may undergo an interview after completing HOPE-C sessions.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationFred Hutch/University of Washington/Seattle Children's Cancer Consortium
Principal InvestigatorMegan J Shen
